Keyphrases
Cirrhosis
97%
Hepatitis C
43%
Decompensated Cirrhosis
40%
Chronic Hepatitis C
35%
Liver Transplantation
32%
Screening Rate
30%
Clinical Outcomes
28%
Hepatorenal Syndrome
25%
Jaundice
25%
Baby Boomers
23%
Curative Treatment
23%
Rehospitalization
21%
Monitoring System
21%
Statins
21%
Primary Care
21%
Statin Use
21%
Non-alcoholic Fatty Liver Disease (NAFLD)
21%
Primary Hepatic Angiosarcoma
21%
Hospitalization
21%
Best Practice Alert
21%
Type 1 Hepatorenal Syndrome
21%
Telephone Monitoring
21%
Potentially Inappropriate Medication
21%
Automated Telephone
21%
Electronic Health Records
21%
IV Drug Use
21%
Meta-analysis
21%
Elder Abuse
21%
Physician Perspective
21%
Primary Care Physicians
21%
Fibrosis Progression
21%
Milwaukee
21%
Randomized Controlled Trial
21%
Osteoporosis
21%
Evidence-based Strategies
21%
High Prevalence
21%
Ocular Toxoplasmosis
21%
Retrospective Analysis
21%
Assessing Risk
21%
Medication Management
21%
Central Vision Loss
21%
Liver Mass
21%
Roux-en-Y Gastric Bypass
21%
Direct-acting Antiviral Therapy
21%
Fibrosis Liver
21%
Systematic Meta-analysis
21%
Alcoholic Hepatitis
21%
Gastric Bypass
21%
Occult
21%
Lessons Learned
21%
Medicine and Dentistry
Liver Cirrhosis
100%
Primary Health Care
43%
Chronic Hepatitis C
34%
Drug Therapy
30%
Liver Graft
28%
Jaundice
26%
Hepatitis C
24%
Fibrosis
24%
Liver Disease
21%
Antiviral Therapy
21%
Angiosarcoma
21%
Gastric Bypass Surgery
21%
Electronic Health Record
21%
Gastric Bypass
21%
Alcohol Consumption
21%
Ocular Toxoplasmosis
21%
Central Scotoma
21%
Quality Improvement
21%
Hepatitis C Virus
21%
Roux-en-Y Gastric Bypass
21%
Prevalence
21%
Osteoporosis
21%
Decompensated Liver Cirrhosis
16%
Weakness
10%
Body Weight Change
10%
Dual-Energy X-Ray Absorptiometry
9%
Cohort Effect
7%
Visual Impairment
7%
Photophobia
7%
Headache
7%
Chronic Liver Disease
7%
Scalp
7%
Diamorphine
7%
Hepatocellular Carcinoma
7%
Toxoplasmic Chorioretinitis
7%
Chorioretinitis
7%
Isoprenaline
7%
Neck
7%
Hemodialysis
6%
Disease
6%
Bisphosphonate
5%
Alcoholic Polyneuropathy
5%
Surgery
5%
Liver Tumor
5%
Observational Study
5%
Liver Injury
5%
Leg Swelling
5%
Disease Management
5%
Paracentesis
5%
Portal Hypertension
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
77%
Decompensated Liver Cirrhosis
49%
Prevalence
43%
Liver Disease
29%
Hepatorenal Syndrome
25%
Ethanol
21%
Nonalcoholic Fatty Liver
21%
Fibrosis
21%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
21%
Chronic Hepatitis C
21%
Statin (Protein)
21%
Liver Cell Carcinoma
14%
Bisphosphonic Acid Derivative
12%
Weakness
10%
Randomized Controlled Trial
10%
Bacterial Peritonitis
8%
Ascites
8%
Osteopenia
8%
Bleeding
8%
Hepatic Encephalopathy
8%
Hepatotoxicity
7%
Oxidoreductase
7%
Chronic Liver Disease
7%
Cardiovascular Disease
7%
Observational Study
5%
Retrospective Study
5%
Jaundice
5%
End Stage Liver Disease
5%
Leg Swelling
5%
Hemodialysis
5%
Disease
5%